#2323 Global Rank Marché Ouvert

Martine Rothblatt

Santé & Biotech. Pharmaceuticals.

Fortune Nette (Est.)

$1.8 B
+$338 (+0.00%) Aujourd'hui
Portefeuille : United Therapeutics ▲ High Growth United Therapeutics ▲ High Growth United Therapeutics ▲ High Growth United Therapeutics ▲ High Growth
Martine Rothblatt

Photo: Press Agency / 2026

Profil Financier

Martine Rothblatt occupe actuellement le rang #2323 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.8 B (+$338 sur 24h).

Martine Rothblatt cofounded Sirius Satellite Radio in 1990 but left soon after the company's 1993 IPO.

Rothblatt moved into biotech after her daughter was diagnosed with pulmonary arterial hypertension, a disease that was deadly at the time.

She founded United Therapeutics in 1996; it sells five FDA-approved drugs to help people with the disease.

The publicly-traded company is experimenting with pig cloning and genetic modification to create lung transplants the human body doesn't reject.

The company's pig 'pharm' in Blacksburg, Virginia is the world's largest cloner of pigs.

Rothblatt is an activist for transgender rights. She and her wife Bina have been married for more than 30 years.

Rothblatt is working to develop the first electric helicopter.

Historique de Fortune (12 Mois)

1A 5A Max
Jan 25 Juin 25 Déc 25 Auj.

Répartition des Actifs

Actif / Société Parts Détenues Valeur Est. Tendance
United Therapeutics (UTHR) 500.0K parts $271 M High Growth
United Therapeutics (UTHR) 100.0K parts $54 M High Growth
United Therapeutics (UTHR) 150.0K parts $81 M High Growth
United Therapeutics (UTHR) 639.5K parts $346 M High Growth
United Therapeutics (UTHR) 244.0K parts $132 M High Growth